WallStreetZenWallStreetZen

NASDAQ: RNTX
Rein Therapeutics Inc Stock Ownership - Who owns Rein Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rein Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rickenbach Josef H. VonDirector2026-05-274,500$1.07
$4.82kBuy
Rickenbach Josef H. VonDirector2026-05-2623,190$1.06
$24.47kBuy
Rickenbach Josef H. VonDirector2026-05-2215,950$1.05
$16.72kBuy
Rickenbach Josef H. VonDirector2026-05-213,420$1.04
$3.56kBuy
James Brian WindsorPresident and Chief Executive Officer2026-04-3025,000$1.00
$25.00kBuy
Voss Capital LP10% Owner2025-11-14104,183$1.23
$127.62kBuy
Voss Capital LP10% Owner2025-10-28178,392$1.39
$247.96kBuy
Voss Capital LP10% Owner2025-10-2792,642$1.37
$126.92kBuy
Voss Capital LP10% Owner2025-10-274,840$1.37
$6.63kBuy
Voss Capital LP10% Owner2025-10-2430,176$1.39
$41.94kBuy

1 of 1

RNTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RNTX insiders and whales buy or sell their stock.

RNTX Shareholders

What type of owners hold Rein Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Muneer A. Satter19.42%16,609,449$16.48MInsider
Voss Capital LP5.13%4,388,362$4.35MInstitution
Reinhard J. Ambros2.98%2,549,982$2.53MInsider
Voss Capital LP2.86%2,442,649$2.42MInsider
Novartis Bioventures Ltd2.43%2,079,394$2.06MInsider
Bios Capital Management LP2.32%1,982,375$1.97MInstitution
Of Texastexas Am Investment Managment Co University2.12%1,810,457$1.80MInsider
University Of Texastexas Am Investment Management Co2.04%1,746,549$1.73MInsider
Brian M. Gallagher Jr.1.67%1,431,519$1.42MInsider
LV Management Group LLC1.28%1,094,987$1.09MInsider

1 of 3

RNTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNTX13.32%42.00%Net BuyingNet Buying
OSTX6.51%14.34%
ACET28.27%71.73%Net BuyingNet Selling
RLYB10.20%89.80%Net BuyingNet Buying
IBIO35.96%64.04%Net Buying
View Top Biotech Stocks

Rein Therapeutics Stock Ownership FAQ

Who owns Rein Therapeutics?

Rein Therapeutics (NASDAQ: RNTX) is owned by 13.32% institutional shareholders, 42.00% Rein Therapeutics insiders, and 44.67% retail investors. Muneer A. Satter is the largest individual Rein Therapeutics shareholder, owning 16.61M shares representing 19.42% of the company. Muneer A. Satter's Rein Therapeutics shares are currently valued at $16.48M.

If you're new to stock investing, here's how to buy Rein Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.